Home / FRAT2 Knockout Cell Lines

FRAT2 Knockout Cell Lines

Gene: FRAT2

Official Full Name: FRAT regulator of WNT signaling pathway 2provided by HGNC

Gene Summary: The protein encoded by this intronless gene belongs to the GSK-3-binding protein family. Studies show that this protein plays a role as a positive regulator of the WNT signaling pathway. It may be upregulated in tumor progression. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO11781 FRAT2 Knockout cell line (HeLa) Human FRAT2 1:3~1:6 Negative Online Inquiry
KO11782 FRAT2 Knockout cell line (HCT 116) Human FRAT2 1:2~1:4 Negative Online Inquiry
KO11783 FRAT2 Knockout cell line (HEK293) Human FRAT2 1:3~1:6 Negative Online Inquiry
KO11784 FRAT2 Knockout cell line (A549) Human FRAT2 1:3~1:4 Negative Online Inquiry

Background

FRAT2 Gene Knockout Cell Lines are specialized cell lines in which the FRAT2 gene has been functionally disrupted through targeted gene-editing techniques, such as CRISPR/Cas9. The FRAT2 gene encodes a regulator that plays a critical role in the Wnt signaling pathway, which is pivotal in processes such as cell proliferation, differentiation, and migration. By creating knockout cell lines, researchers can investigate the specific contributions of FRAT2 to these biological processes, enabling a deeper understanding of tumor biology, developmental pathways, and various disease mechanisms.

The primary function of the FRAT2 knockouts is to elucidate the gene's role within cellular contexts, particularly in cancer research and stem cell biology. The disruption of FRAT2 can lead to altered Wnt signaling, which can be assessed through downstream effects on target genes, cellular morphology, and behavior. This mechanistic insight is invaluable in research environments focused on drug development and therapeutic interventions.

Scientifically, the significance of these cell lines extends to their utility in both in vitro and in vivo models, serving as tools for testing the efficacy of Wnt pathway modulators and evaluating potential therapeutic strategies in diseases where aberrant signaling is implicated. Their applications also encompass fundamental studies aimed at understanding the molecular underpinnings of various cancers, fostering advancements in precision medicine.

The unique selling points of FRAT2 Gene Knockout Cell Lines lie in their specificity and reliability. By providing a controlled genetic background where FRAT2 is absent, these cell lines ensure reproducibility in experiments, minimizing confounding variables often seen with wild-type counterparts. Additionally, researchers benefit from the existing characterization of these lines, thus accelerating project timelines and enhancing the preciseness of experimental outcomes.

For researchers and clinicians, the value of FRAT2 Gene Knockout Cell Lines is clear. They offer a robust platform to dissect the functional roles of FRAT2 in therapeutic contexts and facilitate the pursuit of innovative solutions across a wide range of biomedical fields. Furthermore, our company prides itself on delivering high-quality biological products backed by extensive expertise in gene editing and cell line development, ensuring you have access to the finest tools for your research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.